LPL Financial’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$94.8M Buy
620,427
+12,679
+2% +$1.94M 0.03% 606
2025
Q4
$83.8M Buy
607,748
+56,213
+10% +$7.36M 0.02% 634
2025
Q3
$70.7M Buy
551,535
+91,442
+20% +$11.2M 0.02% 680
2025
Q2
$55.7M Sell
460,093
-5,902
-1% -$665K 0.02% 715
2025
Q1
$51.9M Buy
465,995
+15,776
+4% +$1.68M 0.02% 670
2024
Q4
$43.8M Buy
450,219
+18,630
+4% +$1.99M 0.02% 716
2024
Q3
$49.6M Buy
431,589
+29,495
+7% +$3.35M 0.02% 615
2024
Q2
$42.8M Buy
402,094
+41,046
+11% +$4.12M 0.02% 618
2024
Q1
$34.9M Buy
361,048
+15,026
+4% +$1.54M 0.02% 687
2023
Q4
$34.9M Buy
346,022
+15,980
+5% +$1.54M 0.02% 627
2023
Q3
$33.6M Buy
330,042
+4,510
+1% +$458K 0.02% 594
2023
Q2
$32.8M Buy
325,532
+26,185
+9% +$2.62M 0.02% 583
2023
Q1
$27.5M Sell
299,347
-22,026
-7% -$1.92M 0.02% 627
2022
Q4
$29.2M Buy
321,373
+10,659
+3% +$898K 0.03% 555
2022
Q3
$23.6M Sell
310,714
-14,106
-4% -$1.17M 0.02% 579
2022
Q2
$27.5M Buy
324,820
+45,658
+16% +$4.01M 0.03% 516
2022
Q1
$24.5M Buy
279,162
+28,646
+11% +$2.48M 0.02% 586
2021
Q4
$21.9M Sell
250,516
-15,634
-6% -$1.3M 0.02% 641
2021
Q3
$21.8M Buy
266,150
+2,027
+0.8% +$182K 0.02% 592
2021
Q2
$24.1M Sell
264,123
-3,424
-1% -$305K 0.02% 527
2021
Q1
$22.9M Sell
267,547
-4,899
-2% -$440K 0.03% 493
2020
Q4
$25.7M Buy
272,446
+57,043
+26% +$4.98M 0.03% 399
2020
Q3
$18.7M Sell
215,403
-4,454
-2% -$386K 0.03% 418
2020
Q2
$19.2M Buy
219,857
+12,878
+6% +$1.11M 0.03% 385
2020
Q1
$17.1M Buy
206,979
+10,698
+5% +$954K 0.04% 349
2019
Q4
$18.6M Buy
196,281
+9,737
+5% +$874K 0.03% 381
2019
Q3
$16.2M Buy
186,544
+15,400
+9% +$1.38M 0.03% 379
2019
Q2
$15.6M Buy
171,144
+4,636
+3% +$392K 0.03% 386
2019
Q1
$14.3M Buy
166,508
+11,563
+7% +$928K 0.03% 391
2018
Q4
$11.9M Buy
154,945
+8,049
+5% +$627K 0.03% 399
2018
Q3
$11.3M Buy
146,896
+11,828
+9% +$874K 0.03% 446
2018
Q2
$9.14M Buy
135,068
+11,997
+10% +$828K 0.02% 491
2018
Q1
$8.92M Buy
123,071
+14,648
+14% +$1.12M 0.02% 487
2017
Q4
$8.16M Buy
108,423
+8,838
+9% +$667K 0.02% 471
2017
Q3
$7.66M Buy
99,585
+12,237
+14% +$924K 0.03% 457
2017
Q2
$6.53M Buy
87,348
+69,245
+383% +$4.91M 0.02% 471
2017
Q1
$1.21M Sell
18,103
-945
-5% -$63K 0.01% 1136
2016
Q4
$1.24M Buy
19,048
+8,685
+84% +$563K 0.01% 1071
2016
Q3
$732K Buy
10,363
+321
+3% +$23.4K 0.01% 1423
2016
Q2
$738K Sell
10,042
-230,078
-96% -$15.9M 0.01% 1379
2016
Q1
$15.6M Buy
240,120
+14,141
+6% +$962K 0.04% 324
2015
Q4
$17.5M Buy
225,979
+95,318
+73% +$7.57M 0.05% 307
2015
Q3
$11M Buy
130,661
+6,737
+5% +$600K 0.06% 268
2015
Q2
$11M Buy
123,924
+636
+0.5% +$58.3K 0.06% 297
2015
Q1
$11M Sell
123,288
-17,526
-12% -$1.55M 0.06% 284
2014
Q4
$11.7M Buy
140,814
+19,211
+16% +$1.59M 0.06% 260
2014
Q3
$10.2M Sell
121,603
-14,421
-11% -$1.17M 0.06% 277
2014
Q2
$11M Sell
136,024
-10,341
-7% -$813K 0.06% 260
2014
Q1
$11.2M Sell
146,365
-18,794
-11% -$1.37M 0.07% 249
2013
Q4
$11.9M Buy
165,159
+8,486
+5% +$590K 0.07% 233
2013
Q3
$10.6M Buy
156,673
+11,120
+8% +$736K 0.07% 253
2013
Q2
$9.22M Buy
+145,553
New +$9.47M 0.07% 244

Other funds holding NVS

LPL Financial's NVS Position: Q1 2026 in Review

LPL Financial increased its Novartis (NVS) stake by 2.1% in Q1 2026, buying an estimated $1.94M and bringing the position to 620,427 shares worth $94.8M. The position accounts for 0.03% of the portfolio, ranked #606.

LPL Financial first reported a position in NVS in Q2 2013 and has held it in 52 quarters since. 1,590 funds tracked by Wall St. Rank hold NVS as of Q1 2026.

  • LPL Financial held 620,427 shares of Novartis worth $94.8M as of Q1 2026.
  • LPL Financial bought 12,679 Novartis shares in Q1 2026, an estimated $1.94M.
  • Novartis made up 0.03% of LPL Financial's portfolio in Q1 2026, its #606 holding.
  • LPL Financial first reported a position in Novartis in Q2 2013 and has held it in 52 quarters since.
  • 1,590 funds tracked by Wall St. Rank held Novartis as of Q1 2026.

Based on LPL Financial's 13F filing for Q1 2026, filed 6 May 2026.